RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022
July 25 2022 - 3:05PM
(NASDAQ: RXST) – RxSight, Inc., an ophthalmic
medical device company dedicated to improving the vision of
patients following cataract surgery, today announced that it will
report financial results for the second quarter 2022 after the
market close on Monday, August 8, 2022. The company’s management
will discuss the results during a conference call beginning at 1:30
p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do
so by accessing a live and archived webcast of the event at
www.rxsight.com, on the Investors page in the News and Events
section. Participants may register for the call here. While not
required, it is recommended participants join 10 minutes prior to
the event start. Instructions are provided (including a dial-in
option) to ensure the necessary audio applications are downloaded
and installed.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight can be found at www.rxsight.com.
Company Contact:Shelley ThunenChief Financial
OfficerIR@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024